Literature DB >> 26418788

Validation of Videoconference With Smartphones in Telemedicine Facial Trauma Care: Analysis of Concordance to On-Site Evaluation.

Alexandre Siqueira Franco Fonseca1, Dov Charles Goldenberg, Guilherme Flosi Stocchero, Arthur Vicentini Costa Luiz, Rolf Gemperli.   

Abstract

BACKGROUND: The continental size of some countries and heterogeneous hospital network prevents patients who live in remote areas from getting adequate initial assessment of facial trauma. The authors present an alternative model for trauma assessment by videoconference via smartphones and analyze the concordance between telemedicine and face-to-face management.
METHODS: Fifty patients with either a confirmed or suspected diagnosis of facial trauma were independently evaluated by 2 teams of physicians: Face-to-face and telemedicine-based. The face-to-face team attended patients at bedside (physical examination and computed tomography scan analysis). The telemedicine team consisted of a general surgery resident on duty in the emergency room and a plastic surgeon researcher remotely communicating via smartphones. Both teams answered a questionnaire, which contained data concerning patient's epidemiology, physical examination, computed tomography (CT) scan findings, and treatment option to be followed. Data were analyzed and compared regarding the similarity of answers.
RESULTS: The sample studied was consistent with the literature, showing a predominance of young males. Traffic accidents and personal violence were the main causes of trauma. The concurrency of answers for physical examination findings was considered substantial (κ = 0.720). For CT scan findings, it was almost perfect (κ = 0.899); for defining the treatment option, it was almost perfect (κ = 0.891). High concurrency of face CT scan findings was observed after we calculated the positive predictive value (89.9%), negative predictive value (99.3%), sensitivity (94.2%), specificity (98.8%), and accuracy (98.3%).
CONCLUSIONS: The proposed model to facial assessment trauma by videoconference via smartphones is feasible, showing high concordance level with face-to-face assessment.

Entities:  

Mesh:

Year:  2016        PMID: 26418788     DOI: 10.1097/SAP.0000000000000623

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  6 in total

1.  Plastic Surgery and COVID-19 in the GCC: Fears, Lessons Learned, and the Plan for the Future.

Authors:  Nouf A Al Saud; Shahad N Alanazi; Feras M Alshomer; Abdullah E Kattan; Mohamed A Mrad; Zuhair Al Fardan; Taghreed R Alhumsi
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-09-11

2.  Inter-facility transfer of patients with traumatic intracranial hemorrhage and GCS 14-15: The pilot study of a screening protocol by neurosurgeon to avoid unnecessary transfers.

Authors:  Nima Alan; Song Kim; Nitin Agarwal; Jamie Clarke; Donald M Yealy; Aaron A Cohen-Gadol; Raymond F Sekula
Journal:  J Clin Neurosci       Date:  2020-10-15       Impact factor: 1.961

Review 3.  Telemedicine in Surgical Care in Low- and Middle-Income Countries: A Scoping Review.

Authors:  Eyitayo Omolara Owolabi; Tamlyn Mac Quene; Johnelize Louw; Justine I Davies; Kathryn M Chu
Journal:  World J Surg       Date:  2022-04-15       Impact factor: 3.282

4.  Evaluation of Diagnostic Accuracy and Therapeutic Approach of Dermatologists and Plastic Surgeons To Non-Melanocytic Skin Lesions By Using Telemedicine.

Authors:  Burcu Tugrul; Basak Yalici-Armagan; Hatice Gamze Demirdag; Ozge Gunduz
Journal:  Dermatol Pract Concept       Date:  2022-07-01

5.  Is Tele-Dentistry an Effective Approach for Patient Follow-up in Maxillofacial Surgery.

Authors:  Damla Torul; Kadircan Kahveci; Cigdem Kahveci
Journal:  J Maxillofac Oral Surg       Date:  2021-05-31

Review 6.  A Review of Telemedicine Applications in Otorhinolaryngology: Considerations During the Coronavirus Disease of 2019 Pandemic.

Authors:  Amrita K Singh; David A Kasle; Roy Jiang; Jordan Sukys; Emily L Savoca; Michael Z Lerner; Nikita Kohli
Journal:  Laryngoscope       Date:  2020-10-01       Impact factor: 2.970

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.